10x Genomics Net Cash Flow 2018-2025 | TXG

10x Genomics net cash flow from 2018 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.

10x Genomics Net Cash Flow 2018-2025 | TXG

10x Genomics net cash flow from 2018 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$44B
Tempus AI (TEM)$13.2B
Doximity (DOCS)$12.7B
Hims & Hers Health (HIMS)$9.6B
IRhythm Technologies (IRTC)$5.5B
Hinge Health (HNGE)$4.4B
Privia Health (PRVA)$2.8B
Inspire Medical Systems (INSP)$2.8B
Heartflow (HTFL)$2.6B
Phreesia (PHR)$1.9B
Enovis (ENOV)$1.8B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.4B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.3B
Claritev (CTEV)$1.1B
Evolent Health (EVH)$1.1B
Fulgent Genetics (FLGT)$679M
Zepp Health (ZEPP)$652M
Veradigm (MDRX)$531M
Standard BioTools (LAB)$481M
Talkspace (TALK)$445M
Butterfly Network (BFLY)$405M
Carlsmed (CARL)$354M
TruBridge (TBRG)$300M
Outset Medical (OM)$247M
Health Catalyst (HCAT)$239M
SOPHiA GENETICS SA (SOPH)$234M
Nyxoah SA (NYXH)$213M
KORU Medical Systems (KRMD)$195M